AbCellera Biologics
Vancouver-based company focused on antibody discovery for therapeutics and immune profiling for vaccine research.
11
Funding Rounds
$378.9m
Money raised
Overview
Vancouver-based company focused on antibody discovery for therapeutics and immune profiling for vaccine research.
-
Website:
- Business model: B2B
- Social accounts:
Funding
Funding series
Funding Series Analysis
The company AbCellera Biologics has raised a total of $296.22m in funding over 11 rounds.
Key Insights:
- AbCellera Biologics Series B round, May 27, 2020: $105m
- AbCellera Biologics Grant (money), May 3, 2020: $175.6m
- AbCellera Biologics Grant (money), May 14, 2019: $4.8m
- AbCellera Biologics Series A round: $10m
- AbCellera Biologics venture round, April 2017 : $817.9k
- AbCellera Biologics Inc. funding round, May 2020: $74.5m
- AbCellera Biologics Inc. funding round, August 2018: $7.7m
- AbCellera Biologics Inc. funding round, March 2018: $484.48k
AbCellera Biologics Series B round, May 27, 2020
$105m
AbCellera Biologics Grant (money), May 3, 2020
$175.6m
AbCellera Biologics Grant (money), May 14, 2019
$4.8m
AbCellera Biologics Series A round
$10m
AbCellera Biologics venture round, April 2017
$817.9k
AbCellera Biologics Inc. funding round, May 2020
$74.5m
AbCellera Biologics Inc. funding round, August 2018
$7.7m
AbCellera Biologics Inc. funding round, March 2018
$484.48k
Industries
AbCellera Biologics is active in the following industries: